Ecodi Meditech Pte Ltd
↗Singapore, Singapore
Ecodi Meditech is a Singapore-based pharmaceutical product development consultancy that specializes in enabling clinical Proof of Concept (PoC) for drug candidates in the Asia-Pacific (APAC) region. The firm provides strategic advisory services to multinational corporations (MNCs) and biotech startups, focusing on bridging the gap between early-stage research and late-stage clinical development.
The company offers comprehensive services including clinical trial strategy, medical marketing, data collection and analysis, and regulatory navigation. By leveraging the deep oncology expertise of its leadership, Ecodi Meditech helps clients optimize their drug development pipelines and accelerate the path from Investigational New Drug (IND) applications to New Drug Applications (NDA).
CLASSIFICATION
SIZE & FINANCIALS
Employees:1-50
Revenue:$1M-$5M
Founded:2019
Ownership:private
Status:operating
FUNDING
Stage:Bootstrapped / Self-funded
PIPELINE
Stage:Discovery|Preclinical|Phase 1|Phase 2
Lead Drug Stage:Phase 2 (Service focus)
Modalities:Small molecule, Biologics
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:MNC Pharmaceutical Companies, Biotech Startups in APAC, International Federation of Pharmaceutical Physicians (IFAPP)
COMPETITION
Position:Niche Player
Competitors:Novotech, Tigermed, ClinChoice, George Clinical
LEADERSHIP
Key Executives:
Murphy Liu - Founder & Managing Director
Scientific Founders:Dr. Murphy Liu
LINKS
Website:ecodi.sg
LinkedIn:LinkedIn Profile
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Ecodi Meditech Pte Ltd and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Ecodi Meditech Pte Ltd. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.